Department of Obstetrics and Gynaecology

Zukunft mammographie-basierter Bildgebung [Future of mammography-based imaging] (2014) Schulz-Wendtland R, Wittenberg T, Michel T, Hartmann A, Beckmann M, Rauh C, Judt S, et al. Journal article, Original article Fully automated nipple detection in 3D breast ultrasound images (2014) Wang L, Böhler T, Zöhrer F, Georgii J, Rauh C, Fasching P, Brehm B, et al. Conference contribution Identification of odor active substances in individual low-volume amniotic fluid samples by a sensorially targeted gas chromatographic-olfactometric approach. (2014) Hartmann C, Cupisti S, Dittrich R, Büttner A Journal article Responsiveness of human neonates to the odor of 5α-androst-16-en-3-one: A behavioral paradox? (2014) Loos HM, Doucet S, Soussignan R, Hartmann C, Durand K, Dittrich R, Sagot P, et al. Journal article Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5) (2014) Emons G, Gorchev G, Harter P, Wimberger P, Staehle A, Hanker L, Hilpert F, et al. Journal article Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome (2014) Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, et al. Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study (2014) Lux MP, Sell CS, Fasching P, Seidl-Ertel J, Bani M, Schrauder MG, Jud S, et al. Journal article Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study (2014) Fasching P, Fehm T, Kellner S, De Waal J, Rezal M, Baler B, Baake G, et al. Journal article FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) Fasching P, Jud S, Hauschild M, Kuemmel S, Schuette M, Warm M, Hanf V, et al. Journal article